RALGAPB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.390600E-01
Normal-vs-Stage2
5.903800E-01
Normal-vs-Stage3
1.370400E-01
Normal-vs-Stage4
7.700000E-01
Stage1-vs-Stage2
6.234200E-01
Stage1-vs-Stage3
1.321990E-02
Stage1-vs-Stage4
4.414600E-01
Stage2-vs-Stage3
6.733600E-02
Stage2-vs-Stage4
2.645800E-01
Stage3-vs-Stage4
4.274200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.304400E-01
Normal-vs-AfricanAmerican
8.231400E-01
Normal-vs-Asian
4.033600E-01
Caucasian-vs-AfricanAmerican
2.681400E-01
Caucasian-vs-Asian
3.650200E-01
AfricanAmerican-vs-Asian
1.701550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.819200E-01
Normal-vs-Female
6.343000E-01
Male-vs-Female
8.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.570000E-01
Normal-vs-Age(41-60Yrs)
8.746800E-01
Normal-vs-Age(61-80Yrs)
4.583400E-01
Normal-vs-Age(81-100Yrs)
4.637200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.073800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.964800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.496600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.643770E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.020300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.412200E-01
Normal-vs-Daily Drinker
4.612400E-01
Normal-vs-Weekly Drinker
5.371200E-01
Normal-vs-Occasional Drinker
8.036400E-01
Normal-vs-Social Drinker
9.182000E-01
Non Drinker-vs-Daily Drinker
5.169800E-01
Non Drinker-vs-Weekly Drinker
4.229800E-01
Non Drinker-vs-Occasional Drinker
5.458600E-03
Non Drinker-vs-Social Drinker
9.206300E-02
Daily Drinker-vs-Weekly Drinker
8.466000E-01
Daily Drinker-vs-Occasional Drinker
5.500100E-02
Daily Drinker-vs-Social Drinker
1.748550E-01
Weekly Drinker-vs-Occasional Drinker
1.200800E-01
Weekly Drinker-vs-Social Drinker
2.982200E-01
Occasional Drinker-vs-Social Drinker
8.846800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.269200E-01
Normal-vs-Grade 2
6.419600E-01
Normal-vs-Grade 3
5.834400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.337000E-01
Grade 1-vs-Grade 3
7.975800E-01
Grade 1-vs-Grade 4
3.269200E-01
Grade 2-vs-Grade 3
1.693030E-01
Grade 2-vs-Grade 4
6.419600E-01
Grade 3-vs-Grade 4
5.834400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.301600E-01
Normal-vs-NonDiabetic
6.640200E-01
Diabetic-vs-NonDiabetic
1.472810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.242400E-01
Normal-vs-NoPancreatitis
5.985200E-01
Pancreatitis-vs-NoPancreatitis
9.820800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.498400E-01
Normal-vs-N1
6.013000E-01
N0-vs-N1
7.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.860200E-01
Normal-vs-TP53-NonMutant
9.280800E-01
TP53-Mutant-vs-TP53-NonMutant
4.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
